# Lubiprostone Effects on Visceral Pain Sensitivity

> **NCT01166789** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 62 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Lubiprostone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01166789
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2011-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166789, "Lubiprostone Effects on Visceral Pain Sensitivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01166789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*